renzapride has been researched along with hexamethonium in 2 studies
| Studies (renzapride) | Trials (renzapride) | Recent Studies (post-2010) (renzapride) | Studies (hexamethonium) | Trials (hexamethonium) | Recent Studies (post-2010) (hexamethonium) |
|---|---|---|---|---|---|
| 70 | 12 | 2 | 2,287 | 3 | 129 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pilot, MA; Qin, XY; Scott, M; Thompson, H | 1 |
| Ito, H; Kamato, T; Miyata, K; Nagakura, Y; Nishida, A; Yamano, M | 1 |
2 other study(ies) available for renzapride and hexamethonium
| Article | Year |
|---|---|
Effects of cholinoceptor and 5-hydroxytryptamine3 receptor antagonism on erythromycin-induced canine intestinal motility disruption and emesis.
Topics: Animals; Atropine; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cholinergic Antagonists; Dogs; Electromyography; Erythromycin; Female; Gastrointestinal Motility; Hexamethonium; Hexamethonium Compounds; Injections, Intravenous; Intestine, Small; Male; Metoclopramide; Muscle Contraction; Muscle, Smooth; Serotonin Antagonists; Tropanes; Vomiting | 1993 |
Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs.
Topics: 4-Aminobenzoic Acid; Animals; Benzamides; Benzimidazoles; Biguanides; Bridged Bicyclo Compounds, Heterocyclic; Colon; Dogs; Dose-Response Relationship, Drug; Gastrointestinal Motility; Hexamethonium; Injections, Intravenous; Ketanserin; Male; Methysergide; Muscle Contraction; Muscle, Smooth; para-Aminobenzoates; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship; Transducers | 1996 |